人類利用植物治療疾病的歷史相當久遠。遠在五千年前，銀杏的功
效即被記載於「神農本草經」；另外中國著名的藥物著作「本草綱目」
亦有相關記載。近年來銀杏葉萃取物EGb761 更是引起西方國家的高度
關注，目前許多相關研究指出，銀杏萃取物EGb761 可用以改善年老人
的疾病，例如：暈眩、注意力喪失和失智等，具有影響神經內分泌機制
進而改善認知功能等功效。另外，EGb761 其中ginkgolides 和bilobalide 的
成分則為血小板活化因子(platelet-activating factor, PAF)之拮抗劑可改善血
小板凝集，用於治療哮喘、腦栓塞及心肌梗塞等心腦血管疾病。近來更
有研究報導指出，銀杏萃取物EGb761 具有促進認知(cognitive enhancer)和
緩衝壓力(anti-stress buffer)的功能。
本實驗利用恐懼所促進之動物驚跳反應(fear-potentiated startle)模式，
來研究銀杏萃取物EGb761 對於條件化恐懼學習四個不同階段之生理生
化影響。根據前人所提出之條件化恐懼實驗操作，在四種不同時間點給
予藥物或破壞腦區，分別代表動物在學習條件化恐懼之不同階段表現，
包括對新恐懼記憶的獲取(acquisition)、固化(consolidation)、表現(expression)
及消減(extinction)等。因此本實驗於特定的學習時間點，施以不同濃度的
藥物處理，從實驗結果顯示，銀杏萃取物EGb761 在條件化恐懼模式中，
於不同階段有不同的影響，EGb761 之投予能促進恐懼記憶之獲取和消減
作用；然則對於固化和表現作用則無顯著影響。
另外，前人的研究亦指出，杏仁核中的麩胺酸NMDA 型接受器和條
件化恐懼的消減作用有關，並且麩胺酸NMDA 型接受器拮抗劑對於消減
作用之拮抗需經過蛋白激MAP kinase 之活化。由本實驗的結果亦發
現，無論是周邊的腹腔給予麩胺酸NMDA 型接受器拮抗劑MK-801 或是
於中樞的杏仁核給予MAPK 磷酸化抑制劑U0126 都能有效拮抗EGb761
所促進之消減作用，而且杏仁核區之MAPK 磷酸化表現增加。因此，由
本研究一系列實驗結果推知，EGb761 會透過活化NMDA 接受器及增加
MAPK 的磷酸化，進而調控動物於條件化恐懼之消減作用。
最後，本實驗藉由銀杏萃取物EGb761 此認知功能促進劑來進行研
究，盼能使我們對於其在恐懼記憶形成的相關機轉有所瞭解，進而在消
除恐懼記憶的實驗中有所突破，使銀杏萃取物在開發及臨床上對於恐懼
失調的治療有更多的貢獻及應用。

The leaves of the Ginkgo biloba have been cultivated for their medicinal
properties for several thousands years. It has been used in the treatment of various
common geriatric complaints including vertigo, short-term memory loss, hearing loss,
lack of attention or vigilance. It is also applied for the treatment of cerebral vascular
disorder. Recent results suggest that it can serve as a cognitive enhancer and
anti-stress buffer. It raises a possibility that the extract of ginkgo biloba may have
effects on the fear conditioning. In this study, we used fear potentiated startle to
evaluate the possible effect of Ginkgo biloba extracts on the different stages of fear
conditioning. Briefly, EGb761, a standard extract of Ginkgo biloba was administrated
to the male Sprague- Dawley rats during acquisition、consolidation、expression or
extinction stages of fear conditioning. Results shown that administration of EGb761
30 min prior to the conditioning facilitated acquisition and extinction of conditioned
fear. No significant differences between control group and EGb761 treated group had
been observed in either consolidation or expression of conditioned fear.
The above findings indicate that NMDA receptors within the amygdala play an
important role in conditioned fear extinction. NMDA antagonists block extinction via
activation MAP kinase. Our data show that the effect of EGb761 was blocked by the
MAPK/ERK inhibitors either systemic administration or intra-amygdala infusion.
Therefore, these results indicate that the effect on extinction of EGb761 is mediated
by actions at the MAPK pathway. Finally, these results point to the potential utility of
using EGb761, Ginkgo biloba extract as adjunct pharmacological tools in the
treatment of fear disorders.

Abdel OM, Baiuomy AR, El-batran S, Arbid MS (2004) Evaluation of the
anti-inflammatory, anti-nociceptive and gastric effects of Ginkgo biloba in the rat.
Pharmacol. Res 49:133-142.
Ahlemeyer B, Mwes A, Krieglstein J (1999) Inhibition of serum deprivation and
staurosporine-induced neuronal apoptosis by Ginkgo biloba extract and some of
its constituents. Eur J Pharmacol 367:423-430.
Amri H, Ogwuegbu SO, Boujrad N (1996) In vivo regulation of peripheral-type
benzodiazepine receptor and glucocorticoid synthesis by Ginkgo biloba extracts
EGb 761 and isolated ginkgolides. Endocrinology 137:5707-5718.
Amri H, Drieu K, Papadopoulos V (1997) Ex vivo regulation of adrenal cortical cell
steroid and protein synthesis, in response to adrenocorticotropic hormone
stimulation, by the Ginkgo biloba extract EGb 761 and isolated ginkgolide B.
Endocrinology 138:5415-5426.
Auguet M, and Clostre F (1983) Effects of an extract of Ginkgo biloba and diverse
substances on the phasic and tonic components of the contraction of an isolated
rabbit aorta. Gen Pharmacol 14:277-280.
Bliss TV, and Lomo T (1973) Long-lasting potentiation of synaptic transmission in
the dentate area of the anaesthetized rabbit following stimulation of the perforant
path. J Physiol 232:331-356.
Bouton ME, Rosengard C, Achenbach GG, Peck CA, Brooks DC (1993) Effects of
contextual conditioning and unconditional stimulus presentation on performance
in appetitive conditioning. J Exp Psychol 46B:63-95.
Bouton ME (2004) Context and Behavioral Processes in Extinction. Learn Mem
11:485-494.
Brambilla R, Gnesutta N, Minichiello L, White G, Roylance AJ, Herron CE, Ramsey
M, Wolfer VC, Cestari V, Rossi-Arnaud C, Grant SE, Chapman PF, Lipp H-P,
Sturani E, Klein R (1997) A role for the Ras signaling pathway in synaptic
transmission and long-term memory. Nature 390:281-286.
Bruel A, Gardette J, Berrou E, Droy-Lefaix MT, Picard J (1989) Effects of Ginkgo
biloba extract on glucose transport and glycogen synthesis of cultured smooth
muscle cells from pig aorta. Pharmacol Res 21:241-249.
Cannich A, Wotjak CT, Kamprath K, Hermann H, Lutz B, Marsicano G (2004) CB1
cannabinoid receptors modulate kinase and phosphatase activity during extinction
of conditioned fear in mice. Learn Mem 11:625-632.
Carter RJ, Lione LA, Humby T, Mangiarini L, Mahal A, Bates G P, Dunnett SB,
Morton AJ (1999) Characterization of progressive motor deficits in mice
transgenic for the human Huntington's disease mutation. J Neurosci
19:3248-3257.
Chavez ML, and Chavez PI (1998) Ginkgo (part1): history, use, and pharmacologic
properties. Hospital Pharmacy 33:658-672.
Cheng F, and Siow YL (2001) Inhibition by ginkgolides and bilobalide of the
production of nitric oxide in macrophages (THP-1) but not in endothelial cells
(HUVEC). Biochem Pharmacol 61:503-510.
Chung KF, Dent G, McCusker M, Guinot P, Page CP, Barnes PJ (1987) Effect of a
ginkgolide mixture (BN 52063) in antagonizing skin and platelet responses to
platelet activating factor in man. Lancet 1:248-250.
Collingridge GL, and Lester RA (1989) Excitatory amino acid receptors in the
vertebrate central nervous system. Pharmacol Rev 41:143-210.
Cox J, and Westbrook R (1994) The NMDA receptor antagonist MK-801 blocks
acquisition and extinction of conditioned hypoalgesia responses in the rat.
Quarterly J Exp Psychol 47B:187-210.
Dadds M, Bovbjerg D, Redd W, Cutmore T (1997) Imagery in human classical
conditioning. Psychol Bull 122:89-103.
Das A, Shanker G, Nath C, Pal R, Singh S, Singh H (2002) A comparative study in
rodents of standardized extracts of Bacopa monniera and Ginkgo biloba:
anticholinesterase and cognitive enhancing activities. Pharmacol Biochem Behav
73:893-900.
Davis M (1992) The role of the amygdala in fear-potentiated startle: implication for
animal models of anxiety. Trends Pharmacol sci 13:35-41.
Davis M, Rainnie D, Cassell M (1994) Neurotransmission in the rat amygdala related
to fear and anxiety. Trends Neurosci 17:208-214.
Davis M, Falls WA, Gewirtz J (2000) Neural systems involved in fear inhibition:
extinction and conditioned inhibition. In: Contemporary issues in modeling
psychopathology (Myslobodsky M, Weiner I, eds) pp113-142. Boston: Kluwer.
Davis M (2002) Role of NMDA receptors and MAP kinase in the amygdala in
extinction of fear: clinical implications for exposure therapy. Eur J Neurosci
16:395-398.
Davis M, and Myers KM (2002) The role of glutamate and gamma- aminobutyric acid
in fear extinction: clinical implications for exposure therapy. Biol Psychiatry
52:998-1007.
Debiec J, LeDoux JE, Nader K (2002) Cellular and Systems Reconsolidation
in the Hippocampus. Neuron 36:527-538.
Diamond BJ, Shifflett C, Feiwel N (2000) Ginkgo biloba extract: mechanisms and
clinical indications. Arch phys Med Rehabil 81:668-678.
Di Renzo G (2000) Ginkgo biloba and the central nervous system. Fitoterapia Suppl
1:S43-47.
Doron NN, and LeDoux JE (2000) Cells in the posterior thalamus project to both
amygdale and temporal cortex: a quantitative retrograde double- labeling study in
the rat. J Comp Neurol 425:257-274.
Drieu K (1986) Preparation et definition de l’extrait de Ginkgo biloba. Presse Med
15:1455-1457.
Falls WA, Miserendino MJD, Davis M (1992) Extinction of fear-potentation startle:
blockade by infusion of an NMDA antagonist into the amygdala. J Neurosci
12:854-863.
Falls W, and Davis M (1995) Behavioral and physiological analysis of fear inhibition:
Extinction and conditioned inhibition. In neurobiological and clinical
consequences of stress: From normal adaptation to PTSD, (Philadelphia:
Lippincott-Raven) 177-202.
Fanselow MS (1998) Pavlovian conditioning, negative feedback, and blocking:
Mechanisms that regulate association formation. Neuron 20:625-627.
Farnsworth NR (1990) The Role of ethnopharmacologi in drug development. In
D.J.Chadwick and J. Marsh (eds.) Bioactivity coumponds from plants pp2-21.
Wiley.
Goddard AM, and Charney DS (1997) Toward an integrated neurobiology of panic
disorder. J Clin Psychiatry 58:4-11.
Goelet P, Castellucci VF, Schacher S, Kandel ER (1986) The long and the short of
long-term memory a molecular framework. Nature 322:419-422.
Gomez del Pulgar T, Velasco G, Guzman M (2000) The CB1 cannabinoid receptor is
coupled to the activation of protein kinase B/Akt. J Biochem 347: 369-373.
Goosens KA, William H, Stephen M (2000) A role for amygdaloid PKA and PKC in
the acquisition of long-term conditional fear memories in rats. Behav Brain Res
114:145-152.
Grillon C (2002) Startle reactivity and anxiety disorders: aversive conditioning,
context, and neurobiology. Biol Psychiatry 52:958-975.
Guzowski JF, and McGaugh JL (1997) Antisense oligodeoxy-nucleotide- mediated
disruption of hippocampal cAMP response element binding protein levels impairs
consolidation of memory for water maze training. Proc Natl Acad Sci
94:2693-2698.
Hall J, Thomas KL, Everitt BJ (2001) Cellular imaging of zif268 expression in the
hippocampus and amygdala during contextual and cued fear memory retrieval:
selective activation of hippocampal CA1 neurons during recall of contextual
memories. J Neurosci 21:2186-2193.
Hebb DO (1994) The Organization of Behavior. John Wiley & Sons, New York.
Herry C, and Garcia R (2002) Prefrontal cortex long-term potentiation but not
long-term depression, is associated with the maintenance of extinction of learned
fear in mice. J Neurosci 22:577-583.
Herry C, and Mons N (2004) Resistance to extinction is associated with impaired
immediate early gene induction in medial prefrontal cortex and amygdale. Eur J
Neurosci 20:781-790.
Hibatallah J, Carduner C, Poelman MC (1999) In vivo and in vitro assessment of the
free radical-scavenger activity of ginkgo flavone glycosides at high concentration.
J Pharm Pharmacol 51:1435-1440.
Hoffman JR, Donato A, Robbins SJ (2004) Ginkgo biloba promotes short-term
retention of spatial memory in rats. Pharmacol Biochem Behav 77: 533-539.
Huang YY, and Kandel ER (1998) Postsynaptic induction and PKA-dependent
expression of LTP in the lateral amygdala. Neuron 21:169-178.
Huang YY, Kelsey CM, Kandel ER (2000) Both protein kinase A and
Mitogen-activated protein are required in the amygdala for the macromolecular
synthesis-dependent late phase of long-term potentiation. J Neurosci
20:6317-6325.
Hugues S, Deschaux O, Garcia R (2004) Postextinction infusion of a mitogen-
activated protein kinase inhibitor into the medial prefrontal cortex impairs
memory of the extinction of conditioned fear. Learn Mem 11:540-543.
Huguet F, Drieu K, Piriou A (1994) Decreased cerebral 5-HT1A receptors during
ageing: Reversal by Ginkgo biloba extract (EGb761). J Pharm Pharmacol
46:316-318.
Itokawa H, Totsuka N, Nakahara K (1987) Antitumor principles from Ginkgo biloba
L. Chem Pharm Bull 35:3016-3020.
Jones BJ, and Roberts DJ (1968) A rotarod suitable for quantitation measurement of
motor incoordination in naive mice. Naunun- Schmeidebergs Archives of Pharmacol 259:211.
Killcross S, Robbins TW, Everitt BJ (1997) Different types of fear-conditioned
behaviour mediated by separate nuclei within amygdala. Nature 388: 377-380.
Koch M (2002) Pharmacological support of exposure therapy in anxiety disorders.
Animal experiment studies. Nervenarzt 73:481-483.
Konorski J (1948) Conditioned reflexes and neuronal organization. Cambridge
University Press, London.
LaBar KS, Gatenby JC, Gore JC, LeDoux JE, Phelps EA (1998) Human amygdala
activation during conditioned fear acquisition and extinction: a mixed-trial fMRI
study. Neuron 20:937–945.
Landes P (1997) Market report: Whole Food magzine’s 2nd annual herb market
survey for U.S. health food stores. HerbalGram 40:52.
Le Bars P, Katz MM, Berman N, Itil TM, Freedman AM, Schatzberg AF (1997) A
placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba
for dementia. JAMA 278:1327-1332.
Le Bars PL (2002) Influence of the severity of cognitive impairment on the effect of
Ginkgo biloba extracts EGb761 in Alzheimer’s disease. Neuropsychobiology
45:19-26.
LeDoux JE, Morrison SF, Reis DJ (1986) The geniculo-amygdala projection:
electrophysiological characteristics of cells in a fear conditioning pathway. Society
for Neuroscience 12:748.
LeDoux JE, Cicchetti P, Xagoraris A, Romanski LM (1990a) The lateral amygdala
nucleus: sensory interface of the amygdala in fear conditioning. J Neurosci
10:1062-1069.
LeDoux JE, Frab CF, Ruggiero DA (1990b) Topograhic organization of neurons in the
acoustic thalamus that project to the amygdala. J Neurosci 10:1043-1054.
Lee H, and Kim JJ (1998) Amygdalar NMDA receptors are critical for new fear
learning in previously fear-conditioned rats. J Neurosci 18:8444-8454.
Levy KJ (1975) Comparing variance of several treatments with a control. Educ
Psychol Meas 35:793-796.
Lin CH, Yeh SH, Lin CH, Lu KT, Leu TH, Chang WC, Gean PW (2001) A role for the
PI-3 kinase signaling pathway in fear conditioning and synaptic plasticity in the
amygdala. Neuron 31:841-851.
Lin CH, Lee CC, Gean PW (2003a) Involvement of a calcineurin cascade in amygdale
depotentiation and quenching of fear memory. Mol Pharmacol 63:44-52.
Lin CH, Yeh SH, Lu HY, Gean PW (2003b) The similarities diversities of signal
pathway leading to consolidation of conditioning and consolidation of extinction
of fear memory. J Neurosci 23:8310-8317.
Lovibond PF, Davis NR, O'Flaherty AS (2000) Protection from extinction in human
fear conditioning. Behav Res Ther 38:967-983.
Lu KT, Walker DL, Davis M (2001) Mitogen-activated protein kinase cascade in the
basolateral nucleus of amygdala is involved in extinction of fear-potentiated
startle. J Neurosci 21:162-164.
Maclennan KM, Darlington CL, Smith PF (2002) The CNS effects of Ginkgo biloba
extracts and ginkgolide B. Prog Neurobiol 67:235-257.
Marcilhac A, Dakine N, Bourhim N, Guillaume V, Grino M, Drieu K (1998) Effect of
chronic administration of Ginkgo biloba extract or Ginkgolide on the
hypothalamic-pituitary-adrenal axis in the rat. Life Sci 62(25): 2329-2340.
Maren S, and Fanselow MS (1995) Synaptic plasticity in the basolateral amygdale
induced by hippocampal formation stimulation in vivo. J Neurosci 15:7548-7564.
Marks, I (1987) The development of normal fear: a review. J. Child Psychiatry
28:667-697.
Markus CR, and Lammers JH (2003) Effects of Ginkgo biloba on corticosterone
stress responses after inescapable shock exposure in the rat. Pharmacol Biochem
Behav 76:487-492.
Marsicano G, Wotjak CT, Azad SC, Bisogno T, Rammes G, Cascio MG, Hermann H,
Tang J, Hofmann C, Zieglgansberger W (2002) The endogenous cannabinoid
system controls extinction of aversive memories. Nature 418:530-534.
Mayford M, Bach ME, Huang YY, Lei W, Hawkins RD, Kandel ER (1996) Control
of memory formation through regulated expression of a CaMKII tansgene.
Science 274:1678-1683.
Miserendino MJD, Sananes CB, Melia KR, Davis M (1990) Blocking of acquisition
but not expression of conditioned fear-potentiated startle by NMDA antagonists in
the amygdala. Nature 345:716-718.
Moreau JP, Eck CR, McCabe J, Skinner S (1988) Absorption, distribution, and
excretion of tagged Ginkgo biloba leaf extract in the rat. In: Funfgeld EW, editor.
Rokan, Ginkgo biloba: recent results in pharmacology and clinic. Berlin:
Springer-Verlag 37-45.
Morris RG (1989) Synaptic plasticity and learning: Selective impairment of learning
rats and blockade of long-term potentiation in vivo by the N-methyl-D-aspartate
receptor antagonist AP5. J Neurosci 9:3040-3057.
Myers KM, and Davis M (2002) Behavioral and neural analysis of extinction. Neuron
36:567-584.
Oken BS, Storzbach DM, Kaye JA (1998) The efficacy of Ginkgo biloba on cognitive
function in Alzheimer’s disease. Arch Neurol 55:1409-1415.
Pavlov IP (1927) Conditioned Reflexes. Oxford University Press, London.
Paxinos G, and Watson C (1997) The Rat Brain in Stereotaxic Coordinates, Compact
3rd Edition, Academic Press, San Diego.
Petkov VD, Belcheva S, Petkov VV (2003) Behavioral effects of Ginkgo biloba L.,
Panax ginseng C.A. Mey. and Gincosan. Am J Chin Med 31:841-855.
Pierre S, Jamme I, Droy-Lefaix MT, Nouvelot A, Maixent JM (1999) Ginkgo biloba
extract (EGb761) protects Na,K-ATPase activity during cerebral ischemia in mice.
Neuroreport 10:47–51.
Pietri S, Seguin JR, Arbigny P, Drieu K, Culcasi M (1997) Ginkgo biloba
extract(EGb761)pretreatment limits free radical-induced oxidative stree in patients
undergoing coronary bypass surgery. Cardiovasc Drugs Ther 11: 121-131.
Porsolt RD, Martin P, Lenegre A, Fromage S, Drieu K (1990) Effects of an extract of
Ginkgo biloba (EGb 761) on ‘learned helplessness’ and other models of stress in
rodents. Pharmacol Biochem Behav 36:963-971.
Port RL, and Seybold KS (1998) Manipulation of NMDA-receptor activity alters
extinction of an instrumental response in rats. Physiol Behav 64:391-393.
Quirk GJ, Russo GK, Barron JL, Lebron K (2000) The role of ventromedial prefrontal
cortex in the recovery of extinguished fear. J Neurosci 20:6225-6231.
Rapin JR, Lamproglou I, Drieu K, DeFeudis FV (1994) Demonstration of the
‘anti-stress’ activity of an extract of Ginkgo biloba (EGb761) using a
discrimination learning task. Gen Pharmacol 25:1009-1016.
Richard F, Thompson, Jeansok JK (1996) Memory system in the brain and
localization of memory. Proc Natl Sci USA 93:13438-13444.
Rogan M, Staubli U, LeDoux JE (1997) Fear conditioning induces associative
long-term potentiatal in the amygdala. Nature 390:604-607.
Sapolsky RM (1992) Stress, the Aging Brain, and the Mechanisms of Neuron Death.
Cambridge, MA; MIT Press.
Schafe GE, and LeDoux JE (2000) Memory consolidation of auditory Pavlovian fear
conditioning requires protein synthesis and protein kinase A in the amygdala. J
Neurosci RC96.
Schafe GE, Atkins CM, Swank MW, Bauer EP, Sweatt JD, LeDoux JE (2000)
Activation of ERK/MAP kinase in the amygdala is required for memory
consolidation of pavlovian fear conditioning. J Neurosci 20:8177-8187.
Smith PF, Maclennan K, Darlington CL (1996) The neuroprotective properties of the
Ginkgo biloba leaf: a review of the possible relationship to platelet-activating
factor (PAF). J Ethnopharmacology 50:131-139.
Squire LR, and Zola SM (1996) Structure and function of declarative and
nondeclarative memory system. Proc Natl Acad Sci 93:13515-13514.
Taubenfeld SM, Milekic MH, Monti B, Alberini CM (2001) The consolidation of new
but not reactivated memory requires hippocampal C/EBPbeta. Nat Neurosci
4:813-818.
Vansteenwegen D, Hermans D, Vervliet B, Francken G, Beckers T, Baeyens F, Eelen P
(2004) Return of fear in a human differential conditioning paradigm caused by a
return to the original acquisition context. Behav Res Ther (in press)
Vervliet B, Vansteenwegen D, Baeyens F, Hermans D, Eelen P (2004) Differential
impact of stimulus change after acquisition versus extinction treatment in human
fear conditioning. Behav Res Ther (in press)
Vianna MR, Szapiro G, McGaugh JL, Medina JH, Izquierdo I (2001) Retrieval of
memory for fear-motivated training initates extinction requiring protein synthesis
in the rat hippocampus. Proc Natl Acad Sci 98:12251-12254.
Wagner AR (1981) SOP: A model of automatic memory processing in animal
behavior. In Information processing in animals: Memory mechanisms (eds. N.E.
Spears and R.R. Miller) pp.5-47. Erlbaum, Hillsdale, NJ.
Walker DL, and Davis M (1997) Double dissociation between the involvement of the
bed nucleus of the stria terminalis and the central nucleus of the amygdale in
light-enhanced versus fear-potentiated startle, and extinction. J Neurosci
17:9375-9383.
Walker DL, Ressler KJ, Lu KT, Davis M (2002) Facilitation of conditioned fear
extinction by systemic administration or intra-amygdala infusions of
D-cycloserine assessed with fear-potentiated startle in rats. J Neurosci 22:
2434-2351.
Ward CP, Redd K, Williams BM, Caler JR, Luo Y, McCoy JG (2002) Ginkgo biloba
extract: cognitive enhancer or antistress buffer. Pharmacol Biochem Behav
72:913-922.
Xu MC, Shi RF, Liu JX, Lu YL, He BL (2000) Synthesis of the adsorbent based on
macroporous copclymer MA-DVB beads and its application in purification for the
extracts from Ginkgo Biloba leaves, Reactive & Fuctional Polymers 43:297-304.
Yaniv D, and Richter-Levin, G (2000) LTP in the basal amygdala induced by
perirhinal cortex stimulation, in vivo. Neuroreport 11:525-530.
Zarate R, and Agras W (1994) Psychosocial treatment of phobia and paic disorders.
Psychiatry 57:133-141.